Beijing Yongtai

Founded in China on November 20, 2006, the company is mainly engaged in research and development of EAL ®.

Yongterico

Established in China on June 8, 2018, the company is mainly engaged in the development of CAR-T and TCR-T cells.

Shanghai Yongtai

Established in China on July 2, 2018, a limited company is preparing to commercialize EAL ® products in eastern China. Shanghai Yongtai is wholly owned by Beijing Yongtai.

Guangzhou Yongrui

Established in China on February 27, 2019, a limited company is preparing for the commercialization of EAL ® products in southern China. Guangzhou Yongrui is wholly owned by Beijing Yongtai.

Beijing Weixiao

Founded in China on July 15, 2016, the Company is mainly engaged in the technical development of biological products. After the completion of the acquisition, Beijing Weixiao is a subsidiary of Beijing Yongtai

Ankang Rui and

Established in China on July 3, 2018, The Company is mainly engaged in the technical development, technical services and technical consulting of biomedicine.